Ashwani Gujral of ashwanigujral.com suggests buying Sun Pharma with a stop loss of Rs 388, target of Rs 404 and Cipla with a stop loss of Rs 420, target of Rs 435.
The market is likely to remain in consolidation mode in next week amid corporate earnings, Delhi assembly elections results and domestic data including IIP, CPI and WPI.
Most brokerages feel 2020 could be the year for broader markets to do well
Most experts see FII flows moving towards few largecaps in coming year also
Prakash Gaba of prakashgaba.com recommends buying Jubilant Foodworks with target at Rs 1620 and stop loss at Rs 1582 and SRF with target at Rs 3500 and stop loss at Rs 3380.
Mitesh Thakkar of miteshthakkar.com recommends buying BPCL with a stop loss of Rs 533 for target of Rs 570 and NCC with a stop loss of Rs 59 for target of Rs 65.
Sudarshan Sukhani of s2analytics.com is of the view that one may sell Axis Bank with stop loss at Rs 735 and target of Rs 715.
Morgan Stanley also has overweight rating on Lupin with a target price at Rs 1,003, implying 47 percent potential upside from current levels as it believes the share price will rise in absolute terms over the next 30 days.
According to CLSA, GDP growth in FY20 is likely to be around 6 percent, much lower lower than the RBI's 6.9 percent projection.
Sectors with positive outlooks are real estate, small appliances and branded apparel, while outlook on autos, select staples and global commodities is more cautious.
The Bank Nifty has formed inside bar candlestick pattern on the weekly time frame, indicating directionless move and an intense fight between bulls and bears
A cup and handle is considered a bullish continuation pattern and it is used to identify buying opportunities.
Top 10 stocks which can be considered for investment and may give hefty returns by next Ganesh Chaturthi
The golden rule of investment is to pour money in stocks that are trading at attractive levels compared to their intrinsic value, thus allowing investors to create wealth over a period of time
Umesh Mehta, Head of Research, Samco Securities said the first year of any government is generally turbulent and it may not really cheer the stock market
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
Historically, the midcap and smallcap index haven’t given negative returns for two consecutive years, hence there is a good chance of a recovery from here on
Prakash Gaba of prakashgaba.com recommends buying Sun Pharma with target at Rs 455 and stop loss at Rs 435.
Sudarshan Sukhani of s2analytics.com advises buying Divis Labs with stop loss at Rs 1590 and target of Rs 1650 and Indraprastha Gas with stop loss at Rs 310 and target of Rs 325.
A breach below the 31,100 zones could drag the Bank Nifty into a consolidation phase
Deutsche's top picks are Torrent Pharma, Aurobindo Pharma and Cipla which all are buy calls.
Numbers, reported on May 28 after market hours, were below analyst estimates but adjusted earnings were in line with expectations
On May 16, S&P BSE Oil & Gas rose 1.5 percent, followed by the S&P BSE realty that gained 1.3 percent, and the S&P BSE Power that was up 1.3 percent
Sun Pharma has support around 370-390 but it seems unlikely that the stock will hold on to that level.
We strongly advocate focusing more on stock selection and trade management aspects, said Jayant Manglik of Religare Broking